does pharmacy actually matter or is it forum lore at this point
does pharmacy actually matter or is it forum lore at this point — that is what I am asking, and I have already read the wiki twice.
Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.
Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.
Compared prices across two neighbouring countries and found the difference was mostly pack size once I normalised it.
Tell me where this is wrong. That is the useful part of posting it.
best — the order this archive was captured in
Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.
Assumed a prescription would be honoured across the border. It was not, and the rules are clear once you actually read them.
Assumed a prescription would be honoured across the border.
This is the split the whole board depends on. Authorisation is European; payment is national.
say which country or the thread is useless
a prescription from one member state is not automatically valid in another
the same product has different names and pack sizes across the union
Is this a cross-border question or a domestic one?
Read the published reimbursement criteria where I live rather than asking. Took twenty minutes and answered everything.
ask for the Beipackzettel or the local equivalent, it answers most questions
Apotheke pricing and pharmacy pricing elsewhere are different systems
Apotheke pricing and pharmacy pricing elsewhere are different systems
Adding the practical step — read your own country’s published criteria. They exist and they are definitive.
That shortage notice was national and does not apply where the question is coming from.
the reimbursement criteria are published in most member states
a shortage in one member state is not a shortage in all of them
the reimbursement criteria are published in most member states
Agreed — and normalising pack size before comparing prices is the fix for half these threads.
private pricing varies enormously between neighbouring countries
The variation between pharmacies inside my own country was larger than the variation I had been chasing across the border.
Left up. It names the member state and the pack size, which is all we ask of a pricing post.
Left up.
nl_verzekering is right about cross-border recognition being narrower than the summaries suggest.
This. The published reimbursement criteria are the document to read, and most member states do publish them.
Same. Naming the country in the first line would fix most of the bad advice on this board.
Cosigning on cross-border prescriptions. The rules exist and they are narrower than the summaries suggest.
Agreed that pharmacy margin regulation explains a lot of the price differences people find mysterious.
Agreed that pharmacy margin regulation explains a lot of the price differences people find mysterious.
Disagreeing with this bit: that criterion belongs to one member state and is being quoted as general.
Yes — keep both the prescription and the receipt. Claims processes ask for both and never at a convenient moment.
Are you comparing the same presentation, or different pack sizes?
Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.
Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.
Asked in my own language at a local pharmacy and got a clearer answer in five minutes than a fortnight of forum reading.
- 1a prescription from one member state is not automatically valid in another13 comments in this branch · started by u/marisol_frisk